A cross-sectional cohort of 240 women, aged 30 to 49 years, will be recruited to undergo the Mi~Scan® breast density ass clinical trials

Acceptability of radiofrequency assessment of breast density

This study looks at a new, simple way to check breast density, a risk factor for breast cancer, in younger women (30-49). It uses a device called Mi~Scan® to help identify women who might need earlier check-ups, potentially saving lives.